Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
221 participants
INTERVENTIONAL
2017-11-01
2025-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-invasive Nerve Stimulation and Sleep
NCT04021537
Transcutaneous Vagal Nerve Stimulation in Veterans With Posttraumatic Stress Disorder
NCT05517304
Vagal Nerve Stimulation in mTBI
NCT04437498
Non Invasive Brain Stimulation for PTSD
NCT02442843
Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life
NCT01009112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Noninvasive nerve stimulation type I
This group will receive one type of nerve stimulation
Transcutaneous nerve stimulation location 1
Non-invasive stimulation by transcutaneous electrical nerve stimulation device in test location
Noninvasive nerve stimulation type II
This group will receive second type of nerve stimulation
Transcutaneous nerve stimulation location 1
Non-invasive stimulation by transcutaneous electrical nerve stimulation device in test location
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcutaneous nerve stimulation location 1
Non-invasive stimulation by transcutaneous electrical nerve stimulation device in test location
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* other medical conditions of severity that may impair cognition
* current illicit or prescription drug abuse
* breathing disorder requiring constant use of oxygen
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
US Department of Veterans Affairs
FED
North Florida/South Georgia Veterans Health System
OTHER
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Williamson, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UF Health Jacksonville
Gainesville, Florida, United States
University of Florida
Gainesville, Florida, United States
UF Health Jacksonville
Jacksonville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
i01 rx003140-01a
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
IRB201700541
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.